Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001555192-22-000001
Filing Date
2022-05-27
Accepted
2022-05-27 15:41:36
Documents
1
Effectiveness Date
2022-05-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12608
  Complete submission text file 0001555192-22-000001.txt   13894
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, SUITE 14303 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, SUITE 14303 CAMBRIDGE MA 02139 857-209-0056
Elicio Therapeutics, Inc. (Filer) CIK: 0001555192 (see all company filings)

EIN.: 452966790 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-447361 | Film No.: 22976742
SIC: 2834 Pharmaceutical Preparations